维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="BOOLELL M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Sildenafil,a novel effective oral therapy for male erectile dysfunction显示文摘	Boolell M Gepi-attee S Gingell JC	1996	Br J Urol1996，78，：	1
2	Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial 显示文摘	Califf R M Boolell M Haffner S M	2008	Am Heart J2008，156，4：	1
3	Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction 显示文摘	Boolell M Allen MJ Ballard SA	1996	Int J Impot Res1996，8，：	1
4	Sildenafil: an orally active type 5 cyclic GMP - specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction显示文摘	Boolell M Allen M J Ballard S A	1996	Int J Impot Res1996，8，：	1
5	Sildenafil,a novel effective oral therapy formale erectile dysfunction显示文摘	Boolell M Attee G Gingell JC	1996	British J Urol1996，78，：	1
6	Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance:Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial显示文摘	Califf RM Boolell M Haffner SM	2008	Am Heart J2008，156，4：	1
7	Sildenafil,a novel effective oraltherapy for male erectile dysfunction显示文摘	Boolell M Gep-iAttee S Gingell JC	1996	Br J Urol,1996，78，2：	1
8	Sildenafil : an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction 显示文摘	Boolell M Allen M J Ballard SA	1996	Int J lmpot Res1996，8，2：	1
9	Sildenafil: An orally active type 5 cyclic GMP-specific phosphodi- esterase inhibitor for the treatment of penile erectile dysfunction 显示文摘	Boolell M Allen M J Ballard S A	1996	Int J Impot Res1996，8，2：	1
10	Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance:Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research(NAVIGATOR)Trial显示文摘	Califf RM Boolell M Haffner SM	2008	Am Heart J2008，156，：	1
11	Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial显示文摘	CALIFF RM BOOLELL M HAFFNER SM	2008	Am Heart J2008，156，4：	1
12	Onset and duration of action of sildenafil citrate for the treatment of erectile dysfunction 显示文摘	Eardley I Ellis P Boolell M	2002	Br J Clin Pharmacol2002，53，1：	1
13	Onset and duration of action of sildenafil for the treatment of erectile dysfunction显示文摘	Eardley I Ellis P Boolell M	2002	Br J Clin Pharmaco2002，53，1：	1
14	Prevention of dia- betes and cardiovascular disease in patients with impaired glucose tolerance:rationale and design of the nateglinide and valsartan in impaired glucose tolerance outcomes re- search (NAVIGATOR) trial显示文摘	Califf RM Boolell M Haffner SM et a/	2008	Am Heart J2008，156，1：	1
15	Sildenafil, a novel effective oral therapy for male erectile dysfunction 显示文摘	Boolell M Gepi-Attee S Gingell JC	1996	Br J Urol1996，78，2：	1
16	The Evolution of Therapies in Non-Small Cell Lung Cancer 显示文摘	Boolell V Alamgeer M Watkins DN	2015	Cancers (Basel)2015，7，3：	1
17	Sildenafil, a novel effective oral therapy for male erectile dysfunction显示文摘	Boolell M GepiAttee S Gin-gell JC	1996	Br J Urol1996，78，2：	1
18	Sildenafil: an orally ac tive type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction 显示文摘	Allen M J Ballard SA	1996	Int J Inpot Res1996，8，2：	1
19	Onset and duration of action of sildenafil for the treatment of erectile dysfunction显示文摘	Eardley I Ellis P Boolell M	2002	Br J Clin Pharmacol2002，53，1：	1
20	Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction显示文摘	Boolell M	1996	International Journal of Impotence Research1996，8，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示